12:05 AM EST, 11/10/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We trim our 12-month target price by $6 to $52, valuing EQH shares at 5.8x our newly initiated 2027 operating EPS estimate of $8.90 and at 6.5x our 2026 EPS estimate of $7.95 (lowered today by $0.20), versus the shares' one-year average forward multiple of 7.2x and a peer average of 9x. We cut our 2025 EPS estimate by $0.23 to $5.65. The rebound in operating profitability we are forecasting for 2026 and 2027 assumes EQH successfully executes its restructuring. Results in 2025 have been pressured by these actions, and we forecast operating revenues to be flat to down 5% in 2025, but to rebound to a rise of 3% to 8% in 2026. Weighing execution risk with the shares' current discounted valuation - they are currently trading at 5.7x our 2026 EPS estimate - we view the shares as undervalued versus peers and historical averages.